Skip to content
Screener

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$87.63B-7.4%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$3.19B-13.4%
Cytokinetics logo
CytokineticsCYTK
$1.92B+57.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.87B+8.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$1.08B+49.8%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$420.58M+36.4%

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$4.78B+236%
Enterprise value$4.75B+244%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0.0×
Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:09 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056713
AssetsAs of / March 31, 2026 / (unaudited)As of / December 31, 2025
Total current assets509,792543,385
Property and equipment, net7,3967,831
Operating lease right-of-use asset1,3341,387
Total assets$518,522$552,603
Liabilities and stockholders' equity
Current liabilities
Accounts payable$7,293$6,006
Accrued compensation5,67812,430

Item 1. Financial Statements (Unaudited)

FAQ

What is Edgewise Therapeutics, Inc.'s total assets?
Edgewise Therapeutics, Inc. (EWTX) reported total assets of $518.52M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s total assets changed year-over-year?
Edgewise Therapeutics, Inc.'s total assets increased by 14.1% year-over-year, from $454.39M to $518.52M.
What is the long-term trend for Edgewise Therapeutics, Inc.'s total assets?
Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s total assets has grown at a 33.3% compound annual growth rate (CAGR), from $131.14M to $552.6M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Edgewise Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude